Celgene to Acquire Delinia with Goal of Moving Immunotherapy for Lupus into Testing – Lupus News Today
|
Celgene to Acquire Delinia with Goal of Moving Immunotherapy for Lupus into Testing
Lupus News Today Celgene Corporation announced that it has entered into an agreement to acquire Delinia, a biotech developing therapeutics for autoimmune diseases, including systemic lupus erythematosus (SLE). The acquisition will expand Celgene’s inflammation and … |
Norwich Gazette |
Stem cell registration huge success
Norwich Gazette PARIS- A registration blitz for potential stem cell donors was a huge success Sunday but the organizers, volunteers and family members at the event knew there’s a very slim chance a perfect match was found for Josette Ambeau. Ambeau is one of more than … Josette Ambeau is looking for her OneMatchwww.brantnews.com |
Bryan-College Station Eagle |
Gene therapy: Engineering to feed the world
Bryan-College Station Eagle “Gene editing is a category of methods used to precisely edit or change genetic code,” said Alison Van Eenennaam of the University of California, Davis. “This technology enables researchers to add, delete or replace letters (A, T, C and G) in the code … |
New York Times |
‘The Affair’ Season 3 Finale: A Day in Paris
New York Times No Alison, no Cole, no Gunther, only the briefest glimpse of Helen through a window. “The Affair” wrenched itself away from just about every previous story line in its Season 3 finale on Sunday, reaching a state of suspended narrative animation from … |
New York Times |
‘The Affair’ Season 3 Finale: A Day in Paris
New York Times No Alison, no Cole, no Gunther, only the briefest glimpse of Helen through a window. “The Affair” wrenched itself away from just about every previous story line in its Season 3 finale on Sunday, reaching a state of suspended narrative animation from … |